Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-22-031976
Filing Date
2022-06-09
Accepted
2022-06-09 16:00:47
Documents
12
Period of Report
2022-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 AMENDED CURRENT REPORT ea161330-8ka1_abvc.htm   iXBRL 8-K/A 24175
  Complete submission text file 0001213900-22-031976.txt   196456

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvcvom-20220527.xsd EX-101.SCH 2956
3 XBRL LABEL FILE abvcvom-20220527_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abvcvom-20220527_pre.xml EX-101.PRE 22354
6 EXTRACTED XBRL INSTANCE DOCUMENT ea161330-8ka1_abvc_htm.xml XML 3823
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 221005925
SIC: 2834 Pharmaceutical Preparations